Temi della conferenza
Following two successful virtual experiences, the 3rd JAK Inhibitors Drug Development Summit is making its way to Boston, MA warmly welcoming the JAK inhibitor community back to in-person meetings.
We are uniting this diverse community of world-leading experts from a range of therapeutic backgrounds all tied together by one thing, treating dermatologic, autoimmune, oncologic and many more inflammatory indications through JAK inhibition.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1037489-3?pid=4832
Speakers: Brett King MD, Associate Professor, Dermatology, Yale University School of Medicine, Wilma Bergfeld, MD Director of Dermatopathology Fellowship, The Cleveland Clinic, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1037489-2?pid=4832
Ms. Emily Birt
Categoriedermatologia